Related Experiment Video
Updated: Jun 14, 2025
09:29
An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
Published on: May 13, 2020
11.4K
[Recommendations for Reducing the Environmental Impact of Inhalers in Portugal: Consensus Document]
Luí S Campos1, Paula Rosa2, Pedro Carreiro Martins3
1Hospital CUF Tejo. Lisboa; Conselho Português para a Saúde e Ambiente. Lisboa. Portugal.
Acta Medica Portuguesa
|September 3, 2024
Summary
This study assesses inhaler environmental impact in Portugal, finding pressurized metered-dose inhalers significantly contribute to greenhouse gas emissions. Recommendations are provided to transition towards more sustainable inhaler alternatives, reducing the ecological footprint.
Area of Science:
- Environmental Science
- Public Health
- Respiratory Medicine
Background:
- Pressurized metered-dose inhalers (pMDIs) are widely prescribed for respiratory conditions.
- pMDIs contribute significantly to greenhouse gas emissions due to their propellants.
- There is a growing need to address the environmental impact of medical devices.
Purpose of the Study:
- To evaluate the environmental impact of inhalers in Portugal.
- To assess physician awareness regarding the carbon footprint of inhalers.
- To develop recommendations for reducing the ecological footprint of inhalers.
Main Methods:
- Calculation of the carbon footprint for pMDIs and dry powder inhalers (DPIs) in Portugal.
- Estimation of prescribing physician awareness on inhaler environmental impact.
- Development of a consensus document with recommendations.
Main Results:
- Pressurized metered-dose inhalers have a substantial impact on greenhouse gas emissions in Portugal.
- Physician awareness regarding the environmental impact of inhalers was estimated.
- The study provides a basis for transitioning to more sustainable inhaler options.
Conclusions:
- A significant reduction in the ecological footprint of inhalers is achievable.
- Transitioning to sustainable alternatives is crucial for environmental health.
- Collaborative efforts are needed to implement recommendations and reduce inhaler-related emissions.
Keywords:
AdministrationCarbon FootprintDry Powder InhalersGreenhouse GasesInhalationMetered Dose InhalersNebulizers and VaporizersPortugalMore Related Videos
Related Concept Videos
01:23Inhaled Medications
244
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
244
01:17Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228